Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NARecruitingINTERVENTIONAL
Enrollment

1,050

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

August 6, 2029

Study Completion Date

January 6, 2032

Conditions
Ovarian CancerTriple-Negative Breast CancerHead and Neck CancerCervical CancerSarcoma
Interventions
PROCEDURE

Tumor biopsies / Tumor surgery

"Tumoral tissues samples must be collected at different times points :~* at the time of surgery~* before first cycle of adjuvant treatment (if possible)~* at progression (if possible)~OR~* before neoadjuvant therapy~* at the time of surgery~* before first cycle of adjuvant treatment (if possible)~* at progression (if possible)"

PROCEDURE

Blood withdrawal

"Blood samples must be collected at different times points :~* at the time of surgery or before the beginning of chemoradiotherapy~* after surgery or after chemoradiotherapy~* 6 months after surgery if non recurrence~* before first cycle of adjuvant treatment or before radiotherapy~* before second cycle of adjuvant treatment or after radiotherapy~* at progression~OR~* before neoadjuvant therapy~* during neoadjuvant therapy (post cycle 1)~* at the time of surgery~* 6 months after surgery if non recurrence~* before first cycle of adjuvant treatment or before radiotherapy~* before second cycle of adjuvant treatment or after radiotherapy~* at progression"

Trial Locations (5)

33076

NOT_YET_RECRUITING

Institut Bergonie, Bordeaux

59000

RECRUITING

Centre Oscar Lambret, Lille

69373

NOT_YET_RECRUITING

Centre Leon Berard, Lyon

75005

RECRUITING

Institut Curie, Paris

92210

RECRUITING

Institut Curie Hopital Rene Huguenin, Saint-Cloud

All Listed Sponsors
lead

Institut Curie

OTHER

NCT03017573 - Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) | Biotech Hunter | Biotech Hunter